Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

endocrine · Mechanism Report

Can selenium deficiency, vitamin D deficiency, toxicant-related oxidative stress, and DIO2 variation converge on thyroid autoimmunity and peripheral thyroid hormone metabolism?

Selenium deficiency, vitamin D deficiency, toxicant-related oxidative stress, and DIO2 variation can converge to increase thyroid autoimmunity and impair peripheral thyroid hormone metabolism.

PlausibleJuly 27, 202614 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Autoimmune thyroid susceptibility, selenium deficiency, vitamin D deficiency, toxicant-related oxidative stress, and DIO2 variation can converge on thyroid autoimmunity and peripheral thyroid hormone metabolism.

laying out figure…
4 of 8 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim describes a multi-factor network in which nutritional deficits, genetic variation, and oxidative stress all point toward thyroid autoimmunity. The mechanism framing links these influences to reduced T4-to-T3 conversion, altered deiodinase activity, and localized inflammatory stress that can disrupt thyroid hormone handling. It also places autoimmune susceptibility and tissue-level thyroid dysfunction within the same converging pathway.

Verified conclusion

Autoimmune thyroid susceptibility and impaired peripheral thyroid metabolism are driven by a multi-faceted network of nutritional deficiencies, genetic variations, and environmental stressors.

Clinical evidence of nutritional deficiencies

  • Autoantibody reduction: Clinical trials and meta-analyses show that selenium deficiency and vitamin D deficiency are directly associated with elevated thyroid autoimmunity. Supplementation of both nutrients in deficient patients with Hashimoto's thyroiditis successfully reduces thyroid peroxidase (TPOAb) and thyroglobulin (TGAb) autoantibody titers.
  • Deiodinase synthesis: Severe selenium deficiency directly impairs peripheral thyroxine (T4) to triiodothyronine (T3) conversion, as the deiodinase enzymes (D1, D2, and D3) are selenium-dependent selenoproteins requiring selenocysteine for synthesis and catalytic function.

Mechanistic and genetic pathways

  • DIO2 genetic variation: The DIO2 Thr92Ala (rs225014) polymorphism reduces type 2 deiodinase catalytic activity, lowering tissue-level T3 and serum T3/T4 ratios.
  • Intracellular stress: Mechanistically, the Ala92-DIO2 variant abnormally accumulates in the Golgi apparatus rather than the endoplasmic reticulum. This mislocalization triggers cellular oxidative stress, mitochondrial imbalance, and localized inflammation, leading to tissue-level hypothyroidism.
  • Oxidative convergence: Environmental toxicant-related oxidative stress alters the cellular redox status, which impairs deiodinase function, shifts peripheral metabolism toward inactive reverse T3 (rT3), and drives localized pro-inflammatory signaling that enhances autoimmune susceptibility.

Bottom line

  • Nutritional deficiencies (selenium and vitamin D), genetic DIO2 (rs225014) variations, and toxicant-induced oxidative stress converge to impair peripheral T4-to-T3 activation and disrupt immune tolerance. Correcting micronutrient deficiencies and mitigating oxidative stress can help support deiodinase efficiency and reduce thyroid autoantibody burdens.

References

  1. Selenium Supplementation in Patients with Hashimoto Thyroiditis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials — pmc.ncbi.nlm.nih.gov ↗
  2. The effect of vitamin D and selenomethionine on thyroid ... — pubmed.ncbi.nlm.nih.gov ↗
  3. Effects of vitamin D supplementation on autoantibodies and thyroid function in patients with Hashimoto’s thyroiditis: A systematic review and meta-analysis — pmc.ncbi.nlm.nih.gov ↗
  4. Impact of Vitamin D on Immunopathology of Hashimoto’s Thyroiditis: From Theory to Practice — pmc.ncbi.nlm.nih.gov ↗
  5. Article information — e-enm.org ↗
  6. [PDF] Review Article The Type 2 Deiodinase Thr92Ala Polymorphism Is ... — pdfs.semanticscholar.org ↗
  7. The Type 2 Deiodinase Thr92Ala Polymorphism Is Associated with Higher Body Mass Index and Fasting Glucose Levels: A Systematic Review and Meta-Analysis — pmc.ncbi.nlm.nih.gov ↗
  8. Pathophysiological relevance of deiodinase polymorphism — pmc.ncbi.nlm.nih.gov ↗
  9. Association of Type II 5′ Monodeiodinase Thr92Ala Single Nucleotide Gene Polymorphism and Circulating Thyroid Hormones Among Type 2 Diabetes Mellitus Patients — pmc.ncbi.nlm.nih.gov ↗
  10. DIO2 Thr92Ala Reduces Deiodinase-2 Activity and Serum-T3 ... — academic.oup.com ↗
  11. The Type 2 Deiodinase A/G (Thr92Ala) Polymorphism Is Associated with Decreased Enzyme Velocity and Increased Insulin Resistance in Patients with Type 2 Diabetes Mellitus — academic.oup.com ↗
  12. The Physiological Functions and Polymorphisms of Type II ... — pmc.ncbi.nlm.nih.gov ↗
  13. The Thr92Ala 5' type 2 deiodinase gene polymorphism is associated with a delayed triiodothyronine secretion in response to the thyrotropin-releasing hormone-stimulation test: a pharmacogenomic study. — pmc.ncbi.nlm.nih.gov ↗
  14. Prevalence of Dio2(T92A) polymorphism and its association with thyroid autoimmunity - PubMed — pubmed.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan obstructive sleep apnea lower testosterone in men?→Plausible5 sourcesDoes a non-elevated LH with low testosterone suggest secondary hypogonadism?→